KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UiPath (PATH) Liabilities and Shareholders Equity (2021 - 2026)

UiPath (PATH) has disclosed Liabilities and Shareholders Equity for 5 consecutive years, with $2.9 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 8.74% year-over-year to $2.9 billion, compared with a TTM value of $5.8 billion through Oct 2025, up 7.39%, and an annual FY2025 reading of $2.9 billion, changed N/A over the prior year.
  • Liabilities and Shareholders Equity was $2.9 billion for Q4 2025 at UiPath, up from $2.9 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $2.9 billion in Q4 2025 and bottomed at $866.5 million in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $2.5 billion, with a median of $2.7 billion recorded in 2023.
  • The sharpest move saw Liabilities and Shareholders Equity skyrocketed 196.89% in 2022, then fell 4.44% in 2024.
  • Year by year, Liabilities and Shareholders Equity stood at $2.3 billion in 2021, then rose by 5.55% to $2.4 billion in 2022, then rose by 14.47% to $2.8 billion in 2023, then dropped by 4.44% to $2.7 billion in 2024, then increased by 8.74% to $2.9 billion in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for PATH at $2.9 billion in Q4 2025, $2.9 billion in Q1 2025, and $2.7 billion in Q4 2024.